# FDA Inspection 659051 - Stembanc Inc - April 27, 2010

Source: https://www.keypedia.com/records/fda_inspections/stembanc-inc/59b7f972-fe8b-4f6d-8966-0d61d4db73b9
Source feed: FDA_Inspections

> FDA Inspection 659051 for Stembanc Inc on April 27, 2010. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 659051
- Company Name: Stembanc Inc
- Inspection Date: 2010-04-27
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1242190 - 2024-06-06](https://www.keypedia.com/records/fda_inspections/stembanc-inc/7a505376-1919-49f2-aaf0-8fb15814d61b)
- [FDA Inspection 1153328 - 2021-09-23](https://www.keypedia.com/records/fda_inspections/stembanc-inc/2bd2c3e3-9feb-499a-83ce-eeac16c8a341)
- [FDA Inspection 1153328 - 2021-09-23](https://www.keypedia.com/records/fda_inspections/stembanc-inc/75c84b4c-1ae1-4f7a-9cca-d3e67bea54a8)
- [FDA Inspection 1153328 - 2021-09-23](https://www.keypedia.com/records/fda_inspections/stembanc-inc/93f8432d-adf9-454c-9536-33ed0dea0cd0)
- [FDA Inspection 862242 - 2014-02-12](https://www.keypedia.com/records/fda_inspections/stembanc-inc/05432b6a-b44b-4c03-b2c3-a50e23f7025e)

Company: https://www.keypedia.com/companies/stembanc-inc/ad32a63d-5cde-422f-b60f-e7e1d3e81799

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d